Insulin aspart Clinical Trials

• Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00184600 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Safety and Efficacy of Insulin Detemir plus Insulin Aspart vs. Insulin Glargine plus Insulin Aspart as Mealtime Insulin in Type I Diabetes
  ClinicalTrials.gov Identifier: NCT00095082 - Completed
  Diabetes Mellitus, Type I
  
• Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
  ClinicalTrials.gov Identifier: NCT00428207 - Recruiting
  Type 1 Diabetes Mellitus
  
• A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.
  ClinicalTrials.gov Identifier: NCT00283218 - Completed
  Type 1 Diabetes
  
• Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Pediatric Population
  ClinicalTrials.gov Identifier: NCT00071448 - Completed
  Diabetes Mellitus, Insulin-Dependent
  
• Insulin Detemir plus Insulin Aspart vs. Insulin Glargine plus Insulin Aspart as Mealtime Insulin in Type II Diabetes
  ClinicalTrials.gov Identifier: NCT00097084 - Completed
  Diabetes Mellitus, Type II
  
• Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00469092 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Safety & Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
  ClinicalTrials.gov Identifier: NCT00065130 - Completed
  Gestational Diabetes
  
• South Danish Diabetes Study
  ClinicalTrials.gov Identifier: NCT00121966 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00184626 - Completed
  Diabetes Mellitus, Type 2
  
• Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin
  ClinicalTrials.gov Identifier: NCT00410033 - Completed
  Diabetes Mellitus, Type 1
  
• Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses
  ClinicalTrials.gov Identifier: NCT00513643 - Completed
  Diabetes Mellitus
  
• Lispro MM Intensive Mixture Therapy With Progressive Dose-Titration of Lispro LM or Biphasic Insulin Aspart 30/70
  ClinicalTrials.gov Identifier: NCT00393705 - Recruiting
  Type II Diabetes Mellitus
  
• A 3 Month, Randomized, Open Label, Multi-Center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine
  ClinicalTrials.gov Identifier: NCT00539396 - Completed
  Diabetes Mellitus, Type 1
  
• Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00097071 - Completed
  Diabetes Mellitus, Type I
  
• Efficacy and Safety of Insulin Aspart Vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00365170 - Completed
  Diabetes Mellitus
  
• Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00434954 - Recruiting
  Type 2 Diabetes Mellitus
  
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs
  ClinicalTrials.gov Identifier: NCT00537277 - Recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00282451 - Completed
  Diabetes Mellitus, Type 2
  
• Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00184613 - Completed
  Diabetes Mellitus, Type 2
  
• Comparison of Insulins Aspart and Lispro in Insulin Pumps
  ClinicalTrials.gov Identifier: NCT00461331 - Completed
  Type 1 Diabetes Mellitus
  
• Efficacy and Safety of Insulin Aspart Vs. Glibenclamide Thrice Daily in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00267683 - Terminated
  Diabetes Mellitus, Type 2
  
• 12 week,comparing safety of HMR1964 & insulin aspart used in continuous subcutaneous infusion in type 1 diabetes.
  ClinicalTrials.gov Identifier: NCT00046150 - Completed
  Diabetes, type I
  
• Insulin Glulisine Administered Premeal Vs Postmeal in Adult Subjects with Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
  ClinicalTrials.gov Identifier: NCT00135096 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Comparison of Insulin Detemir Given Once Or Twice Daily in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00117780 - Completed
  Diabetes Mellitus, Type 1
  
• Efficacy and Safety of Inhaled Insulin Compared with Subcutaneous Human Insulin Therapy in Adults with Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00137046 - Active, not recruiting
  Diabetes Mellitus
  
• Efficacy and Safety of Inhaled Insulin Compared with Subcutaneous Human Insulin Therapy in Adults with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00136916 - Active, not recruiting
  Diabetes Mellitus
  
• Study of Recombinant Human Insulin-Like Growth Factor I in Patients with Severe Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00004419 - Recruiting
  Insulin Resistance; Hyperglycemia
  
• A Trial to Study the Effect of Vitamin D Supplementation on Glucose and Insulin Metabolism in Centrally Obese Men
  ClinicalTrials.gov Identifier: NCT00347542 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent; Obesity
  
• Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00545805 - Enrolling by invitation
  Insulin Resistance; Obesity; Metabolic Syndrome X
  
• Insulin NovoRapid Vs. Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
  ClinicalTrials.gov Identifier: NCT00145353 - Active, not recruiting
  Type 1 diabetes mellitus
  
• The Effect of Calcium Supplementation on Insulin Resistance and 24h Blood Pressure
  ClinicalTrials.gov Identifier: NCT00549536 - Active, not recruiting
  Hypertension; Diabetes; Insulin Resistance
  
• Insulin Treatment Variation in Southwestern Diabetics
  ClinicalTrials.gov Identifier: NCT00148304 - Active, not recruiting
  Diabetes; Insulin; Blood Glucose Monitoring
  
• Insulin on Post Burn Hypermetabolism
  ClinicalTrials.gov Identifier: NCT00137254 - Active, not recruiting
  Burns
  
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
  ClinicalTrials.gov Identifier: NCT00211536 - Active, not recruiting
  Type 1 Diabetes
  
• Effect of Salicylate on Glucose Metabolism in Insulin Resistance States
  ClinicalTrials.gov Identifier: NCT00258128 - Active, not recruiting
  Insulin Resistance
  
• Study of Response in CHC Patients Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (Study P04823)
  ClinicalTrials.gov Identifier: NCT00493805 - Recruiting
  Hepatitis C, Chronic; Insulin Resistance; Homeostasis Model Assessment of Insulin Resistance
  
• Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes.
  ClinicalTrials.gov Identifier: NCT00184561 - Completed
  Diabetes Mellitus, Type 2
  
• Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00280046 - Completed
  Diabetes Mellitus, Type 2
  
• Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00571935 - Completed
  Type 1 Diabetes Mellitus
  
• Self-Control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart
  ClinicalTrials.gov Identifier: NCT00494988 - Completed
  Type 2 Diabetes Mellitus
  
• Effect of Leptin Therapy in the Treatment of Severe Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00085982 - Recruiting
  Insulin Resistance
  
• A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00467649 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Bypass Angioplasty Revascularization Investigation in Type 2 Diabetics (BARI 2D)
  ClinicalTrials.gov Identifier: NCT00006305 - Active, not recruiting
  Coronary Disease; Cardiovascular Diseases; Heart Diseases; Insulin Resistance; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent
  
• Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
  ClinicalTrials.gov Identifier: NCT00313001 - Completed
  Diabetes Mellitus, Type 2
  
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
  ClinicalTrials.gov Identifier: NCT00329225 - Active, not recruiting
  Non-Insulin-Dependent Diabetes Mellitus
  
• Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00435019 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00440284 - Active, not recruiting
  Type 2 Diabetes
  
• Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00467376 - Recruiting
  Diabetes Mellitus
  
• Influence of Insulin on BP Change During Adolescence
  ClinicalTrials.gov Identifier: NCT00007098 - Active, not recruiting
  Cardiovascular Diseases; Hypertension; Obesity; Insulin Resistance; Diabetes Mellitus
  
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
  ClinicalTrials.gov Identifier: NCT00309244 - Recruiting
  Diabetes Mellitus, Type 2
  
• Effect of Growth Hormone on Insulin Signaling in Muscle Tissue
  ClinicalTrials.gov Identifier: NCT00477997 - Recruiting
  Insulin Resistance
  
• Metabolic Studies- Interactions Between GH and Insulin in GHDA
  ClinicalTrials.gov Identifier: NCT00568568 - Recruiting
  Insulin Resistance
  
• Treating the Endothelium to Restore Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00402194 - Recruiting
  Obesity; Insulin Resistance; Dysglycemia/Pre-Diabetes
  
• Effect of EGCG on the Body's Response to Insulin
  ClinicalTrials.gov Identifier: NCT00434499 - Recruiting
  Hypertension; Obesity; Type 2 Diabetes; Insulin Resistance
  
• Exercise in Insulin-Resistant Minority Adolescents
  ClinicalTrials.gov Identifier: NCT00345436 - Recruiting
  Insulin-Resistance
  
• Initiation of Insulin Aspart in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00572806 - Completed
  Type 2 Diabetes Mellitus
  
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00332488 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Prenatal Nutrition and Adult Disease
  ClinicalTrials.gov Identifier: NCT00024583 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent; Insulin Resistance; Obesity; Hypertension
  
• Dietary Protein and Insulin Sensitivity Study
  ClinicalTrials.gov Identifier: NCT00508937 - Recruiting
  Insulin Resistance; Type 2 Diabetes; Metabolic Syndrome; Cardiovascular Disease; Dyslipidemia
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00564668 - Completed
  Type 2 Diabetes Mellitus
  
• Recombinant Human Insulin-Like Growth Factor (rhIGF-1)Treatment of Short Stature Associated with IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00125190 - Active, not recruiting
  Insulin-Like Growth Factor-1 Deficiency; Primary IGF-1 Deficiency; IGF-1
  
• Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion
  ClinicalTrials.gov Identifier: NCT00188773 - Recruiting
  Insulin Resistance Syndrome X; Pancreatic Beta Cell Function
  
• Identification and therapy efficacy of Type 2 diabetes in Hispanic patients
  ClinicalTrials.gov Identifier: NCT00004572 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
  ClinicalTrials.gov Identifier: NCT00476437 - Completed
  Diabetes Mellitus, Type 2
  
• Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00286962 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
  ClinicalTrials.gov Identifier: NCT00185705 - Recruiting
  Hypertension; Insulin Resistance; Dyslipidemia
  
• Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
  ClinicalTrials.gov Identifier: NCT00006505 - Active, not recruiting
  Insulin Dependent Diabetes Mellitus
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004699 - Active, not recruiting
  Hyperinsulinism
  
• Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
  ClinicalTrials.gov Identifier: NCT00338949 - Recruiting
  Schizophrenia; Metabolic Syndrome X; Insulin Resistance
  
• Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
  ClinicalTrials.gov Identifier: NCT00259168 - Recruiting
  Insulin Resistance; Impaired Fasting Glucose
  
• The Roles of Cytokines in the Mechanism of Insulin Resistance and Energy Balance
  ClinicalTrials.gov Identifier: NCT00172614 - Recruiting
  Metabolic Syndrome X; Cachexia; Insulin Resistance
  
• Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU
  ClinicalTrials.gov Identifier: NCT00394524 - Recruiting
  Diabetes or With New Hyperglycemia
  
• Dietary Advanced Glycation End-Products and Insulin Resistance in Overweight and Obese Humans
  ClinicalTrials.gov Identifier: NCT00422253 - Recruiting
  Type 2 Diabetes; Insulin Resistance; Obesity
  
• Rosiglitazone and Insulin Resistance in Renally Impaired Patients
  ClinicalTrials.gov Identifier: NCT00452166 - Recruiting
  Chronic Kidney Disease; Insulin Resistance
  
• Health Related QOL, Depression and Lifestyle Changes in Insulin Resistant Adolescents
  ClinicalTrials.gov Identifier: NCT00493259 - Recruiting
  Insulin Resistance; Depression
  
• Study of Fat Cell Turnover in Subjects With and Without Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00560469 - Recruiting
  Adipocyte Differentiation; Insulin Resistance
  
• The Role of Insulin Resistance in PCOS
  ClinicalTrials.gov Identifier: NCT00173043 - Recruiting
  Polycystic Ovary Syndrome; Insulin Resistance; Obesity
  
• Predicting Insulin Resistance in American Indian Youth
  ClinicalTrials.gov Identifier: NCT00498030 - Recruiting
  Insulin Resistance; Stress, Psychological
  
• Effects of Fish Oils on Inflammation and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00579436 - Recruiting
  Metabolic Syndrome; Insulin Resistance
  
• Insulin Resistance in Severely Obese Patients
  ClinicalTrials.gov Identifier: NCT00275223 - Recruiting
  Obesity; Insulin Resistance; Diabetes
  
• Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetes and Obesity
  ClinicalTrials.gov Identifier: NCT00443755 - Recruiting
  Type 2 Diabetes; Insulin Resistance
  
• Exenatide Compared with Twice-Daily Biphasic Insulin Aspart in Patients with Type 2 Diabetes Using Sulfonylurea and Metformin
  ClinicalTrials.gov Identifier: NCT00082407 - Completed
  Diabetes Mellitus, Type 2
  
• Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004700 - Active, not recruiting
  Hyperinsulinism
  
• Insulin Resistance in Non-Alcoholic Steatohepatitis
  ClinicalTrials.gov Identifier: NCT00252499 - Recruiting
  Insulin Resistance; Fatty Liver
  
• Oatmeal and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00401453 - Recruiting
  Diabetes Mellitus Type 2; Insulin Resistance
  
• Diabetes Therapy to Improve BMI and Lung Function in CF
  ClinicalTrials.gov Identifier: NCT00072904 - Completed
  Cystic Fibrosis; Diabetes Mellitus
  
• A Study Comparing Subcutaneous Rapid Acting Insulin and Two Formulations of Inhaled Insulin in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00570687 - Recruiting
  Diabetes Mellitus: Type 2
  
• Insulin Resistance Atherosclerosis Study (IRAS)
  ClinicalTrials.gov Identifier: NCT00005135 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Diabetes Mellitus; Heart Diseases; Obesity; Insulin Resistance
  
• Comparison of Insulin Detemir and NPH Insulin in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily. The Pediatric Mixing Trial.
  ClinicalTrials.gov Identifier: NCT00542620 - Recruiting
  Diabetes Mellitus, Type 1
  
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00330733 - Recruiting
  NIDDM; Cardiovascular Disease; Atherosclerosis; Insulin Resistance; Inflammation
  
• Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00370617 - Recruiting
  Chronic Hepatitis C; Insulin Resistance
  
• Efficacy and Safety of Insulin Detemir Versus NPH Insulin in Pregnant Women With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00474045 - Recruiting
  Diabetes Mellitus, Type 1
  
• Treating Periodontal Infection: Effects on Glycemic Control in People with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00016835 - Active, not recruiting
  Periodontal Disease; Diabetes Mellitus, Non-Insulin-Dependent
  
• Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00506662 - Recruiting
  Diabetes Mellitus, Type 2
  
• Mechanisms of Insulin Resistance in Humans
  ClinicalTrials.gov Identifier: NCT00330967 - Recruiting
  Insulin Resistance; Inflammation
  
• Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics
  ClinicalTrials.gov Identifier: NCT00057499 - Active, not recruiting
  Insulin-Dependent Diabetes Mellitus; Diabetes Mellitus
  
• Rosiglitazone to Reverse Metabolic Defects in Diabetes
  ClinicalTrials.gov Identifier: NCT00094796 - Active, not recruiting
  Diabetes Mellitus, Type II; Insulin Resistance